Large doses of salicylates have been reported to prevent diabetic glycosuria in man and the drug was used in the treatment of diabetes during the latter part of the last century (Gross & Greenberg, 1948) .
General arrangement of experiments Effect of salicylate on the glycosuria of alloxan-diabetic rats.
Eight diabetic rats were placed in metabolism cages and 24 hr. urine collections made. After an initial control period, each rat received a daily suboutaneous injection of 100 mg. ofsodium salicylate suspended in arachis oil. After a second control period, each rat received a daily subcutaneous injection of an arachis oil suspension of 100 mg. of sodium gentisate. After a further recovery period each rat received 10 mg. of cortisone (cortone acetate, Merck). The rats were weighed daily and a fasting blood glucose was estimated on alternate days.
Effect of salicylkte on blood glucose of diabetic rats. Six diabetic rats, maintained under fasting conditions for 12 hr. before and during the experiment, were given a solution containing 100 mg. sodium salicylate in 1 ml. distilled water by subcutaneousinjection. Bloodglucose was determined on tail-vein samples immediately before and 4, 7 and 24 hr. Effect of salicylate on liver glycogen and blood glucose of normal rats. The previous experiment was repeated with normal rats which had received extra glucose in the preceding 24 hr. period (cf. Lutwak-Mann, 1942) .
RESULTS
The effects of salicylate on the glycosuria of alloxandiabetic rats. The mean 24 hr. glucose outputs are shown in Fig. 1 (Meyer & Ragan, 1948) to exert similar therapeutic actions to sali-cylate, had no significant effect, whereas cortisone exacerbated the glycosuria. When the injection of salicylate was stopped the 24 hr. excretion ofglucose increased to higher levels than were observed during the initial control period. A similar effect was reported by Ingle (1950) . No significant differences in blood-glucose concentrations were observed during the whole experiment. During the initial control period there was a slow but steady loss of body weight, but no further decrease in weight occurred after the animals had received salicylate. The injection of salicylate did not cause any reduction in daily food intake.
The effect of salicylate on thefasting blood glucose of alloxan-diabetic rats. Table 1 shows that there was no significant difference between the two groups of rats at the start of the experiment, but that a significant fall in blood glucose occurred in alloxandiabetic rats treated with salicylate and this fall is significantly different from any deviations observed in the untreated diabetic animals.
Three ofthe salicylate-treated rats died during the course of the experiment and one of these had a blood-glucose value of 44 mg./100 ml. immediately before death. This suggests that hypoglycaemia may have been a major factor in the death of these animals. ' The effect of 8alicylate on the liver glycogen of alloxan-diabetic rats. A comparison between the blood-glucose concentrations at the start of the experiment and those determined immediately before death showed a significant fall in the salicylate-treated, but not in the control rats, a similar effect to that observed in the previous experiment. Table 2 shows that despite this fall in blood glucose no significant change occurred in the liver-glycogen content. In the comparison of the liver-glycogen results from untreated and salicylate-treated rats no value of P less than 0-3 was obtained.
The effect of salicylate on the blood glUcose and liver glycogen of nornl rats. Table 3 shows that there was no significant change of blood glucose in the salicylate-treated rats, but that a marked fall in liver glycogen occurred 4 and 7 hr. after the salicylate injection. This depletion appeared to be temporary and partial replacement of the glycogen had occurred in 24 hr. Our results are in agreement with those reported by Lutwak-Mann (1942) , except that this worker found in some experiments that 24 hr. after treatment, glycogen in the livers of salicylatetreated rats was greater than that of the controls.
DISCUSSION
The present work shows that in diabetic rats salicylate reduces the glycosuria, lowers the blood glucose, but causes no change in liver-glycogen content. Cortisone exacerbated the glycosuria in these animals and this is of interest because of reports that the therapeutic effects of salicylate are primarily mediated through the pituitary and adrenal glands, a hypothesis which has been criticized (Meade & Smith, 1951) . It must be concluded that in diabetic rats depression in the urinary and blood glucose by salicylate is not due to its deposition as liver glycogen. Other possible mechanisms to account for the disappearance of this glucose are: first, inhibition of gluconeogenesis; second, increased deposition of muscle glycogen; third, increased glucose use in the tissues; and fourth, conversion to fat.
In the non-diabetic rat salicylate caused no change in blood glucose, but a significant reduction of liver glycogen and similar mechanis may be involved. The possibility that the glucose may be converted to glucuronic acid which is used for conjugation with salicylate is unlikely because of Lutwak-Mann's (1942) conclusion that the ability of rat liver to form a conjugated glucuronide from salicylate was negligible.
It is proposed to extend this work to investigate the possibilities discussed above. SUMMARY 1. The effect of salicylate on the glycosuria, blood glucose and liver-glycogen content of the alloxan-diabetic rat and on the blood glucose and liver glycogen of the normal rat have been studied.
2. Salicylate reduces the glycosuria and blood glucose in the diabetic rat, but causes no change in the liver-glycogen content. In the normal rat salicylate causes no alteration in the blood glucose, but a depression of the liver-glycogen content.
3. Possible mechanisms of these changes are discussed.
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